new at HIVMA
Congratulations to the 2010 HIVMA Leadership Award Winners
Every year, the HIV Medicine Association (HIVMA) recognizes
an HIV clinical educator and researcher that have changed the way we think
about HIV disease or our approach to patient care. In addition, this year HIVMA
also presented the 2010 HIVMA Association Citation, a discretionary award given
by the HIVMA Board in recognition of exemplary contribution to the Association.
The awards were presented at the 48th Annual Meeting of IDSA in Vancouver
Please consider recognizing a colleague’s work by nominating
him or her for the 2011 leadership Awards. Details are available online or by e-mailing email@example.com.
The Clinical Educator
award acknowledges an HIVMA member who has demonstrated significant achievement
in the area of HIV clinical care and medical education by acquiring and
disseminating information on HIV disease beyond a single institution.
Mark W. Kline, MD,
FIDSA, has been treating children with HIV since the epidemic first
surfaced among children in the late 1980s. His investigations of clinical
therapies have led to successful treatments allowing children with HIV/AIDS to
reach adulthood with a quality of life unimaginable 15 years ago. He also built
a network of children’s HIV/AIDS centers across Africa staffed by the Pediatric
AIDS Corps. Dr. Kline is currently the J.S. Abercrombie Professor and chairman
of the Department of Pediatrics at Baylor College of Medicine and
physician-in-chief of Texas Children’s Hospital.
HIV Research Award
The HIV Research Award
is given to an HIVMA member who has made outstanding contributions to HIV medicine
in clinical or basic research early in his or her career. The award is based on
innovation and originality and requires demonstration of significant
independent research and productivity. For the first time since the inception
of the HIVMA awards, HIVMA recognized the important work of two researchers
whose nomination submissions received near identical scores.
Peter W. Hunt, MD,
is an assistant adjunct professor of medicine at the University of California,
San Francisco. His research has led to crucial discoveries about elevated
immune activation during long-term HAART, persistent elevated immune activation
in long-term control of HIV infection in the absence of therapy, and the
negative consequences of this on both the immune system and the cardiovascular
system. He also helped establish the Uganda AIDS Rural Treatment Outcomes
cohort, one of only a few rigorous biologically oriented clinical cohorts in
rural Africa. The cohort recently completed a project demonstrating that T cell
activation is markedly elevated in untreated Africans, that T cell activation
remains elevated during therapy, and that the degree of T cell activation on
therapy predicts mortality.
David M. Smith III,
MD, MAS, is an assistant professor of medicine in the Department of Medicine
at the University of California, San Diego (UCSD) and director of the HIV/HCV
and HIV/HPV Co-Infection Clinics in the Special Infectious Diseases Program at
the Veterans Affairs Medical Center in San Diego. His research focuses on
understanding the pathogenesis of HIV to inform the development of biomedical
interventions to interrupt HIV transmission. Most recently, he demonstrated for
the first time phylogenetic evidence that cell-free RNA in seminal plasma is
the origin of sexually transmitted virus between men who have sex with men.
HIVMA Leadership Citation
This year, HIVMA presented a special discretionary award in
recognition of exemplary contribution to the Association to Daniel Kuritzkes, MD, FIDSA. As a founding Board member in 2001, Dr.
Kuritzkes has played a vital role in establishing HIVMA as a globally
recognized organizational home representing HIV clinicians and scientists and
the needs of their patients. Under Dr. Kuritzkes’ leadership as HIVMA Chair,
HIVMA launched the Minority Clinical Fellowship Award program, which will be
one of his most enduring accomplishments. The highly successful program is now in
its fourth year supporting African American and Latino physicians in pursuing
careers in HIV medicine working with underserved populations.
Dr. Kuritzkes also serves as the co-editor of HIVMA’s annual
compendium, Clinical Issues in HIV
Medicine, and is a member of the IDSA/HIVMA Center for Global Health
Policy’s Scientific Advisory Committee. He is a professor of medicine at
Harvard Medical School and currently is the director of the AIDS Research
Section of Retroviral Therapeutics at Brigham and Women’s Hospital in Boston,
chair of the executive committee of the Adult AIDS Clinical Trials Group
(ACTG), and the director and principal investigator of the Harvard Adult AIDS
Clinical Trials Unit.